| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/20/2001 | EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108024A1 Lim domain protein homolog |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1108022A1 Cell specific promoters of uncoupling protein 3 |
| 06/20/2001 | EP1108021A2 Human genes differentially expressed in colorectal cancer |
| 06/20/2001 | EP1108020A1 Glycine transporter |
| 06/20/2001 | EP1108019A2 Protein transport-associated molecules |
| 06/20/2001 | EP1108018A1 Human deltex-like gene zdx |
| 06/20/2001 | EP1108017A2 G-motif oligonucleotides and uses thereof |
| 06/20/2001 | EP1108016A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 06/20/2001 | EP1108015A1 Streptavidin mutants having secondary functional domains |
| 06/20/2001 | EP1108014A1 $i(EHRLICHIA CANIS) 120-KDA IMMUNODOMINANT ANTIGENIC PROTEIN AND GENE |
| 06/20/2001 | EP1108013A2 Genes associated with neurotransmitter processing |
| 06/20/2001 | EP1108012A2 Mutant egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 06/20/2001 | EP1108010A1 Salt-tolerant transgenic turfgrass |
| 06/20/2001 | EP1108009A1 Compositions and methods for producing high-level seed-specific gene expression in corn |
| 06/20/2001 | EP1108008A1 Novel ubiquitin ligases as therapeutic targets |
| 06/20/2001 | EP1108006A1 Self-contained device integrating nucleic acid extraction, amplification and detection |
| 06/20/2001 | EP1107996A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 06/20/2001 | EP1107994A2 Monoclonal antibodies against s100 |
| 06/20/2001 | EP1107993A1 Human monoclonal antibodies directed against the islet cell antigen ia-2 |
| 06/20/2001 | EP1107990A1 High-affinity antibodies |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107987A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 06/20/2001 | EP1107984A1 Modified synthetic dna sequences for improved insecticidal control |
| 06/20/2001 | EP1107978A1 Secreted proteins and polynucleotides encoding them |
| 06/20/2001 | EP1107977A1 Ratc |
| 06/20/2001 | EP1107975A1 Synthetic fatty acid desaturase gene for expression in plants |
| 06/20/2001 | EP1107799A1 Method for labeling biopolymers using isotopes |
| 06/20/2001 | EP1107798A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 06/20/2001 | EP1107797A2 Hypoxia regulated genes |
| 06/20/2001 | EP1107796A2 Cells expressing immunoregulatory molecules and uses therefor |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107780A2 Selective treatment of endothelial somatostatin receptors |
| 06/20/2001 | EP1107774A1 Ramp2a: receptor activity modifying protein-2a |
| 06/20/2001 | EP1107772A2 Probiotic, lactic acid-producing bacteria and uses thereof |
| 06/20/2001 | EP1107768A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| 06/20/2001 | EP1107723A2 A carotenoid composition containing phytoene and phytofluene |
| 06/20/2001 | EP1107702A1 Ultrasonic enhancement of drug injection |
| 06/20/2001 | EP1107662A1 Manipulation of tocopherol levels in transgenic plants |
| 06/20/2001 | EP1107661A2 Plant fatty acid desaturase promoters |
| 06/20/2001 | EP0842188A4 Mutant s182 genes |
| 06/20/2001 | EP0662157B1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/20/2001 | EP0652954B1 A novel gene vector coding human epidermal growth factor and process for preparing the same |
| 06/20/2001 | EP0618962B1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 06/20/2001 | CN1300338A Vibration control member formed integrally with elasto-plastic and viscoelastic damper |
| 06/20/2001 | CN1300325A Amphotropic retrovirus packaging cell line, process for its production and use thereof |
| 06/20/2001 | CN1300324A Glyphosate as a gametocide |
| 06/20/2001 | CN1300323A Recombinant (alpha)-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 06/20/2001 | CN1300322A Novel gene combinations that alter the quality and functionality of soybean oil |
| 06/20/2001 | CN1300321A Method for the production of 1,3-propanediol by recombinant organisms compising for vitamin B12 transport |
| 06/20/2001 | CN1300294A Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B and their use |
| 06/20/2001 | CN1300222A Strategically modified hepatitis b core proteins and their derivatives |
| 06/20/2001 | CN1299973A HCV-free-blood external preparing method |
| 06/20/2001 | CN1299873A Gene synthesis, expression plasmid construction and product production of human 16 interferon |
| 06/20/2001 | CN1299872A Gene synthesis, expression plasmid construction and product production of human alpha 26 interferon |
| 06/20/2001 | CN1299871A Human originating promoter for human body cell to express exogenous gene efficiently |
| 06/20/2001 | CN1299870A Lycoris agglutinin protein and its code sequence |
| 06/20/2001 | CN1299868A Construction and use of recombinant herpes simplex virus |
| 06/20/2001 | CN1299832A New human cell cycle regulating protein and its code sequence and use |
| 06/20/2001 | CN1299831A New interferon-like protein and its code sequence and use |
| 06/20/2001 | CN1299830A New human heat shock protein and its code sequence and use |
| 06/20/2001 | CN1299829A New human cell cycle regulating protein and its code sequence and use |
| 06/20/2001 | CN1299828A New cell factor acceptor and its code sequence and use |
| 06/20/2001 | CN1299827A New human CD20 homolgous molecule and its code sequence and use |
| 06/20/2001 | CN1299825A New human zinc finger transcription factor and its code sequence |
| 06/20/2001 | CN1299824A New human coupling acceptor and its code sequence |
| 06/20/2001 | CN1299823A New human cell factor and its code sequence and use |
| 06/20/2001 | CN1299822A New complex process of preparing recombined isomer of tissue-type plasminogen activator |
| 06/20/2001 | CN1067460C Pumping device |
| 06/20/2001 | CN1067431C Process for construction and purifying of recombinant human lymph toxin alpha deriv a |
| 06/19/2001 | US6248939 Corn plants and products with improved oil composition |
| 06/19/2001 | US6248938 Animal feed compositions containing phytase derived from transgenic alfalfa and methods of use thereof |
| 06/19/2001 | US6248937 Transcription factor and method for regulation of seed development, quality and stress-tolerance |
| 06/19/2001 | US6248936 Sugarbeet storage-root-tissue-specific regulon |
| 06/19/2001 | US6248935 Nucleotide sequences coding regulatory protein associated with pollen formation; for use in controlled gene expression in plant anthers |
| 06/19/2001 | US6248934 Gene trap vectors |
| 06/19/2001 | US6248876 Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases |
| 06/19/2001 | US6248875 Nucleotide sequence coding brain protein; for use in diagnosis of central nervous system defects |
| 06/19/2001 | US6248873 Nucleotide sequences associated with cardiovascular disorders; for the detection of genetic adjustment in the genome |
| 06/19/2001 | US6248872 Nucleotide sequences which code enzymatic protein; for use in detection and treatment of dirofilaria infection |
| 06/19/2001 | US6248868 Phragmoplastin and methods of examining cell plate development |
| 06/19/2001 | US6248867 Polypeptide associated with proper eye function; for the diagnosis of vision defects |
| 06/19/2001 | US6248724 Antisense oligonucleotide compositions targeted to angiotensin converting enzyme MRNA and methods of use |
| 06/19/2001 | US6248715 Administering non-fucosylated polypeptide for treatment of metastasis, inflammation, rheumatoid arthritis, eye diseases |
| 06/19/2001 | US6248714 Methods of inhibiting binding and treating Ig-mediated responses with IL-13 receptor |
| 06/19/2001 | US6248712 Urokinase-type plasminogen activator receptor |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248589 Recombinant hepatitis C virus RNA replicase |
| 06/19/2001 | US6248586 Antisense modulation of PKA catalytic subunit C-alpha expression |
| 06/19/2001 | US6248584 Nucleic acid encoding a p100 transcription coactivator of defined amino acid sequence or the complement of the nucleic acid; for altered levels of activator in transformed host cells such as plants and seeds |
| 06/19/2001 | US6248582 Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| 06/19/2001 | US6248581 Mycobacteria functional screening and/or expression vectors |
| 06/19/2001 | US6248579 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 06/19/2001 | US6248578 Infectious clone for human parainfluenza virus type 3 |
| 06/19/2001 | US6248577 Amino acid sequence of dimeric protein from plasmodium falciparum; enzyme inhibitors for treatment of malaria |
| 06/19/2001 | US6248576 Histidinol dehydrogenase |
| 06/19/2001 | US6248574 Fusion protein of polypeptide derived from gp41 or gp120 of defined amino acid sequence and a non-human immunodeficiency virus polypeptide sequence; diagnosis; immunotherapy; immunotoxins; vaccines |